{"name":"Simcha IL-18, Inc.","slug":"simcha-il-18-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNT0RDdEdiUC1wR213VFBwQXotR2w5LXE3TWxyeUF5TnhiM09sZ0VkOGlkMElqNDZiRkY4cjJ4TXY3cEZ2ZGthMDd6b0l1dE1lMjkwekpzYmVnYlVTaG44VWw4enZBTTFhbGdqY1FVU1VfWXF6Y0ZKOGJoOF9GVWw1SWFtVQ?oc=5","date":"2025-05-27","type":"pipeline","source":"labiotech.eu","summary":"9 biotechs making waves in interleukin therapeutics in 2025 - labiotech.eu","headline":"9 biotechs making waves in interleukin therapeutics in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPbUxEOHhuQVlGZ1UtTFZMdkQzWlZfbVAwNDh6NmF6UjZCTUZUTDBwQTBpT1prcHdwbVFZbHBEV3p6QmJaUllXa3NrMUhKaUNXUFJJSnIyZEQzR2s0cHNVVDNJRlJLVEhJU0tXUFVhTWxBbUpNME4tUVhNdk9kXzMxSEl4REVTcS02NWpUWFhORGFzdGFEUkZ3b2tIa19tSGtseGJ3UGdMSzdGWmI5SXJ6a1R3NXZnMzFNeUE?oc=5","date":"2025-01-27","type":"regulatory","source":"Fierce Biotech","summary":"Nippon Shinyaku to pay $36M to reserve US rights to AB2 Bio's near-approval autoimmune drug - Fierce Biotech","headline":"Nippon Shinyaku to pay $36M to reserve US rights to AB2 Bio's near-approval autoimmune drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNRHRVT1A4Y2VjU3dkWE5uUDNVVW9RdFFMWnhfZjBfRnJTZG8tVXNyYTBQM3B6VFdKSmZxc0Q5TkUxdjI5azFnWWVwZDJFVjYwaGdkajRQZHJ5N1VmMkMwMkNfeWhjWXRoWHFtTC1NZEF0Zm9Gd1FITnllUlk4U1hibkRRdy12cVFBVXFKN2lRWTY5NXZfTlkweTdweG9qVTNqMXdzQTdDWGl2OTdWclBvV2JEUE51aVRTS1hUSjFpN2I3M3E1Nm4tUzd0NUVuSHF1bFd5RlBhMTRRMmYtYUpWSTc2TTBoRVV0MlJwSndJNVIyMjJaZFd6Q19CdTE?oc=5","date":"2024-12-05","type":"regulatory","source":"businesswire.com","summary":"Simcha Therapeutics Announces the Opening of Two Clinical Studies Exploring ST-067 in Hematological Indications - businesswire.com","headline":"Simcha Therapeutics Announces the Opening of Two Clinical Studies Exploring ST-067 in Hematological Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWUdYazYzNkxhVDM3T2lMYU5EcGJqYkhSVU9ObGgwTm1hZC13ekRvVGtVSjBYYWxXRk1LTTBsMGxkbmJTX1RfWk84b2pzUFJMWWVCempFT3B3SnpzanB6SmJXVVREMXZVbjNab2t4UmlkSmtrU2gxRnBKOVJ0dy1sMlpSMzBKWWZmV1Y1bFdRcnE4M3pmMElPTzlpTkVzbUNJUkxlUGVRVmdFS3M?oc=5","date":"2024-04-10","type":"trial","source":"Fierce Biotech","summary":"AACR: Mural debuts preclinical data for potential cytokine therapy pipeline additions - Fierce Biotech","headline":"AACR: Mural debuts preclinical data for potential cytokine therapy pipeline additions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPaEJQMHhUeFlueXhOQ3VFSTBQeUhhZExVbXNzeWFVUV9xM1R1QU5OYkkzbDB6SW52VHVkOGU1bVRoNkV4dDljbTI4Uk1YdENmdC0yMDA4U0xzZXlyRGd5NEFPRWxqNDIwZlk3WXFSNkEtU2ZMUWxURDdzZmRJc08yRF9Ja0lFSmE2Tk5wVmQ4Mi1SRGpXZm1RZXNGWFpzbHhadWVvYy1GblhHZTJFQktCNHRBa3FEd2ZGb1RpNzRtemxYVl94OXU5Wm0wbEgydjl0NHk4bWZyd2tBM09BTnRNYWJ4d2lXQ1A3ZjN1Rjd6SmJyUGdqQThvb2Z2cVdwOTdlVmlYaVBQUDJYV1d0TkxFaTBaNFRYQQ?oc=5","date":"2024-01-08","type":"deal","source":"businesswire.com","summary":"Simcha Therapeutics Announces License & Option Agreement to Develop Novel Decoy-resistant IL-18 for Use in Cell Therapy Applications - businesswire.com","headline":"Simcha Therapeutics Announces License & Option Agreement to Develop Novel Decoy-resistant IL-18 for Use in Cell Therapy ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOWTQ5Ni1MaVQyMENnY0ZJZFE2R3pCVE0xY0FIZnJXazdHMGRlOTVmYkx2aUFhYTRiajBaLTJzRmE1LU1jTnR6ZXNaLVdHbG8xd2xlZWdCdjVqZjNpSTVWYTFTSXpHTWdtaHJHWmc5NEk4dkFBbDlpRkdjeWdENGNLRGk0aUFJRVhjX095WDVubS1US1poWkVkUkRRZTYxQlFMRE5zcHh0TTdySnRvaDQwdkxwZW5vZ2Y4YkZ0RC1zUVluVGxmb1E?oc=5","date":"2023-09-20","type":"pipeline","source":"BioWorld News","summary":"Not just another cytokine? Simcha looks to rejuvenate IL-18 field with decoy resistance - BioWorld News","headline":"Not just another cytokine? Simcha looks to rejuvenate IL-18 field with decoy resistance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQclUzRHp4NFJfRE4zVGx1ZVQ3c0RiSVcxbXVMc3Q3NDRRQVJ4cDRFalBvc3RsUUx0bkZldG9meXVkd05yVkxKSG8yaDRqS1laQWhlbUpzNmkxY2hva19HaEVIZUIyWVV0WEUzR19xNWdKRTBQM1N1QUx0SHRYQ2FuU1RTN2VBd1p3eGxxblpWMlo1WWl0dVppbWxn?oc=5","date":"2022-08-16","type":"pipeline","source":"citybiz","summary":"Simcha Therapeutics Appoints Sanuj Ravindran, M.D., as CEO - citybiz","headline":"Simcha Therapeutics Appoints Sanuj Ravindran, M.D., as CEO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}